Labshake search

1 - 6 of 6 citations for Camostat Mesylate d4 since 2020

• D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity

  Jie Hu, et al., bioRxiv - Microbiology 2020

  Quote: ... Camostat mesylate (Tokyo Chemical Industry, Tokyo, Japan), and aloxistatin (E-64d ...
• Rho-ROCK liberates sequestered claudin for rapid de novo tight junction formation

  Yuma Cho, et al., bioRxiv - Cell Biology 2024

  Quote: ... Camostat Mesylate (C2977; Tokyo Chemical Industry Co., Ltd.).
• β-adrenergic blockers increase cAMP and stimulate insulin secretion through a PKA/RYR2/TRPM5 pathway in pancreatic β-cells in vitro

  Naoya Murao, et al., bioRxiv - Cell Biology 2024

  Quote: ... phentolamine mesylate (Tokyo Chemical Industry, Tokyo ...
• The anticoagulant nafamostat potently inhibits SARS-CoV-2 infection in vitro: an existing drug with multiple possible therapeutic effects

  Mizuki Yamamoto, et al., bioRxiv - Microbiology 2020

  Quote: ... gabexate mesylate (Tokyo Chemical Industry, Tokyo, Japan), edoxaban ...
• The anticoagulant nafamostat potently inhibits SARS-CoV-2 infection in vitro: an existing drug with multiple possible therapeutic effects

  Mizuki Yamamoto, et al., bioRxiv - Microbiology 2020

  Quote: Nafamostat mesylate (Tokyo Chemical Industry, Tokyo, Japan), camostat mesylate (Wako ...
• Metalloproteinase-dependent and TMPRSS2-independnt cell surface entry pathway of SARS-CoV-2 requires the furin-cleavage site and the S2 domain of spike protein

  Mizuki Yamamoto, et al., bioRxiv - Microbiology 2021

  Quote: Nafamostat mesylate (N0959, Tokyo Chemical Industry, Tokyo, Japan), pepstatin A (4397 ...